Company / Current Liabilities
Arcutis Biotherapeutics, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$129.8M
FY2025
5-year range
$33.3M / $129.8M
FY2021-FY2025
Trend
+60.3%
vs FY2024
Sector context
#84 of 213
Health Care
What the data says
At $130M, Arcutis Biotherapeutics, Inc.'s current liabilities ranks #130 of 213 in the Health Care sector. Current Liabilities has increased for 6 consecutive years, from $5M in FY2019 to $130M in FY2025.
Based on SEC 10-K filings.
$130M in FY2025 with a 5-year CAGR of +41.9%.
Increased from $47M to $130M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +50.9%
- 5-Year CAGR
- +41.9%
- 10-Year CAGR
- -
Sector benchmark
#130 of 213 in Health CareTop 61% of 213This company $129.8M Sector average $1.6B
▼
-91.8% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s current liabilities has grown for 6 consecutive years.
- 5-year CAGR of +41.9%, indicating consistent growth.
- In FY2025, current liabilities increased 60.3% year-over-year.
- Ranks #84 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $129.8M | +60.3% |
| FY2024 | $81.0M | +73.6% |
| FY2023 | $46.7M | +23.4% |
| FY2022 | $37.8M | +13.4% |
| FY2021 | $33.3M | +47.4% |
| FY2020 | $22.6M | +331.6% |
| FY2019 | $5.2M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026